Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Anti-IL-13 Antibody (H2L6)

Copy Product Info
🥰Excellent
Catalog No. T9901A-1317
Alias H2L6

Anti-IL-13 Antibody (H2L6) is a humanized monoclonal antibody specifically targeting human interleukin-13 (IL-13). The compound binds to IL-13 with high affinity, effectively blocking its interaction with the receptor complex (IL-13Ra1 and IL-4Ra), thereby inhibiting downstream signaling such as STAT6 phosphorylation. As IL-13 is a key driver of Th2-mediated immune responses, H2L6 is widely utilized in preclinical research for asthma, atopic dermatitis, and other allergic or inflammatory disorders.

Anti-IL-13 Antibody (H2L6)

Anti-IL-13 Antibody (H2L6)

Copy Product Info
🥰Excellent
Catalog No. T9901A-1317Alias H2L6
Anti-IL-13 Antibody (H2L6) is a humanized monoclonal antibody specifically targeting human interleukin-13 (IL-13). The compound binds to IL-13 with high affinity, effectively blocking its interaction with the receptor complex (IL-13Ra1 and IL-4Ra), thereby inhibiting downstream signaling such as STAT6 phosphorylation. As IL-13 is a key driver of Th2-mediated immune responses, H2L6 is widely utilized in preclinical research for asthma, atopic dermatitis, and other allergic or inflammatory disorders.
TargetMol
Product information is being updated, if you want to purchase, please click the bulk custom button.
Add to Quotation
Questions
TargetMol
View More

Product Introduction

Bioactivity
Description
Anti-IL-13 Antibody (H2L6) is a humanized monoclonal antibody specifically targeting human interleukin-13 (IL-13). The compound binds to IL-13 with high affinity, effectively blocking its interaction with the receptor complex (IL-13Ra1 and IL-4Ra), thereby inhibiting downstream signaling such as STAT6 phosphorylation. As IL-13 is a key driver of Th2-mediated immune responses, H2L6 is widely utilized in preclinical research for asthma, atopic dermatitis, and other allergic or inflammatory disorders.
Targets&IC50
IL-13:35 pM(Kd)
In vitro
In Surface Plasmon Resonance (SPR) assays, Anti-IL-13 Antibody (H2L6) exhibited a high affinity for human IL-13 with a KD of approximately 35 pM. In functional cell-based assays using TF-1 cells, H2L6 dose-dependently neutralized IL-13-induced STAT6 phosphorylation with an IC50 of approximately 46 pM [1].
In vivo
In preclinical models of Th2-driven inflammation, systemic administration of Anti-IL-13 Antibody (H2L6) successfully inhibited IL-13-mediated biological effects, including the reduction of inflammatory cytokine release and attenuation of tissue eosinophilia, demonstrating its potential in managing allergic airway inflammation [1].
SynonymsH2L6
Clone
H2L6
Reactivity
Human
Application
FACS
Functional assay
Antibody Type
Monoclonal
FormulationSupplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition.
Endotoxin<1.0 EU/mg
Related Conjugates and Formulations
Conjucates
Unconjugated
Antigen Details
Uniprot ID
TargetIL-13
Chemical Properties
Antibody Information
IsotypeIgG1
Storage & Solubility Information
Storagestore at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature.

Calculator

  • Dilution Calculator
  • Reconstitution Calculator
Related Tags: buy Anti-IL-13 Antibody (H2L6) | purchase Anti-IL-13 Antibody (H2L6) | Anti-IL-13 Antibody (H2L6) cost | order Anti-IL-13 Antibody (H2L6) | Anti-IL-13 Antibody (H2L6) in vivo | Anti-IL-13 Antibody (H2L6) in vitro